Atsushi Igarashi
Papers
1
Total Citations
4
H-Index
1
About
Dr. Atsushi Igarashi is a leading urologic oncologist whose research focuses on optimizing treatment strategies for high-risk and very high-risk prostate cancer. His major contributions center on evaluating the efficacy and safety of neoadjuvant chemohormonal therapy prior to radical prostatectomy, with a particular emphasis on patient compliance and its impact on long-term outcomes. In his pivotal 2024 study, Dr. Igarashi demonstrated that dose compliance with a regimen combining degarelix acetate and low-dose estramustine phosphate is a significant predictor of biochemical recurrence in patients with very high-risk prostate cancer undergoing robot-assisted radical prostatectomy. This work, which has already garnered 4 citations, provides critical insights into personalized treatment intensification. By systematically analyzing a cohort of 187 patients, Dr. Igarashi has helped clarify the therapeutic window for neoadjuvant approaches, directly informing clinical decision-making for this challenging patient population. His research bridges the gap between pharmaceutical compliance and oncologic control, offering a practical framework for improving outcomes in aggressive prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1